UCLA ( Site 0317) — Los Angeles, California

UCLA ( Site 0317) is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA ( Site 0317) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA ( Site 0317)?

UCLA ( Site 0317) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA ( Site 0317) conducted?

UCLA ( Site 0317) has 1 clinical trials on record, with 1 currently active. Their work covers Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer.

Is UCLA ( Site 0317) accredited by Crixeo Health?

UCLA ( Site 0317) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA ( Site 0317)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.